.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Express Scripts
Federal Trade Commission
Fuji
Novartis
Argus Health
Cerilliant
Queensland Health
Deloitte

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 071981

« Back to Dashboard
NDA 071981 describes DROPERIDOL, which is a drug marketed by Astrazeneca, Igi Labs Inc, Watson Labs, Luitpold, Hospira, Smith And Nephew, Solopak, and Abraxis Pharm, and is included in seventeen NDAs. It is available from three suppliers. Additional details are available on the DROPERIDOL profile page.

The generic ingredient in DROPERIDOL is droperidol. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the droperidol profile page.

Summary for 071981

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 071981

Mechanism of ActionDopamine D2 Antagonists

Medical Subject Heading (MeSH) Categories for 071981

Suppliers and Packaging for NDA: 071981

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DROPERIDOL
droperidol
INJECTABLE;INJECTION 071981 ANDA Hospira, Inc. 0409-1187 0409-1187-01 10 AMPULE in 1 CARTON (0409-1187-01) > 2 mL in 1 AMPULE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2.5MG/ML
Approval Date:Feb 29, 1988TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Harvard Business School
Medtronic
Citi
Chubb
UBS
AstraZeneca
US Army
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot